PRIA Logo™
115-hr-5782115th Congress

Opioid Crisis Accountability Act of 2018

Sponsored By: Representative Gabbard, Tulsi [D-HI-2]

Unknown

Summary

Opioid Crisis Accountability Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks, supplying states or communities with a quantity of opioids that is not medically necessary, or failing to report any order or pattern of orders that would cause a reasonable person to believe the opioids were not being dispensed in a medically reasonable manner.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Gabbard, Tulsi [D-HI-2]

HI • D

Cosponsors

  • Rep. Jackson Lee, Sheila [D-TX-18]

    TX • D

    Sponsored 11/20/2018

  • Rep. Khanna, Ro [D-CA-17]

    CA • D

    Sponsored 5/11/2018

  • Rep. Jayapal, Pramila [D-WA-7]

    WA • D

    Sponsored 5/16/2018

  • Rep. Raskin, Jamie [D-MD-8]

    MD • D

    Sponsored 11/6/2018

  • Sen. Welch, Peter [D-VT]

    VT • D

    Sponsored 11/6/2018

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation